expression differences, that is, population specific due to presence of a relatively new SNP or stratification of a common SNP by population. Thus, gene expression studies using subjects with mixed genetic backgrounds can be affected by genetic variation that alters probe hybridization on microarray platforms. We caution that ethnic gene expression differences recently reported by Spielman et al. 3 may be accounted for by ethnic specific probes causing differential hybridization to cDNA since B40% of the Affymetrix probes contain SNPs.
In conclusion, we propose using exon array probelevel analysis to obtain coding SNPs genotypic information by comparing probes that contain SNPs to probes that do not contain SNPs. Of the 1.99 million Affymetrix probes on the exon array that contain an SNP, it is estimated that the strongest disruption of hybridization will occur when the SNP is located within the middle 15 bp of probe sequence, which occurs 127 404 times on the exon array with a minor-allele frequency X5%. This means that there are at least 127 404 common exonic SNPs with a maximal hybridization effect on the chip. This analysis can provide in one array genotype-specific expression in cDNA. The combination of expression and genotypic data from the same subjects using the same platform should allow a very efficient study of cis-regulatory variation. In the central nervous system, tryptophan hydroxylase 2 (TPH2) catalyzes the rate limiting step in the biosynthesis of serotonin, a neurotransmitter involved in many aspects of brain function, including regulation of affect state, aggression and impulsivity. Variants in the TPH2 sequence have been associated with a spectrum of psychiatric diagnoses, such as obsessive compulsive disorder, affective disorders and attention-deficit/hyperactivity disorder (ADHD). [1] [2] [3] [4] [5] [6] It has been proposed that naturally occurring variants of TPH2 with decreased enzyme activity could cause deficiency of serotonin production and an increased risk of developing affective disorders. 3 However, all the TPH2 variants described so far are either situated in non-coding regions or are missense mutations with significant residual activity. 2, 3, 7 To examine the role of the TPH2 gene in ADHD, we sequenced all exons and flanking introns of TPH2, as well as 1200 and 1000 base pairs upstream and downstream of the start and stop codons, respectively, in 94 Norwegian adult ADHD patients. The recruitment strategy and inclusion criteria of this sample have recently been described. 8 The project was approved by the Regional Committee for Medical Research Ethics of Western Norway. We found several previously reported polymorphic sites in the TPH2 sequence. In addition, we discovered a novel variant in exon 7, c.907 C > T, corresponding to a heterozygous R303W missense mutation in a female ADHD patient. TPH2 exon 7 was then genotyped in 323 additional ADHD patients and 87 ethnically matched populationderived controls without finding the c.907 C > T, or any other missense mutations.
Segregation analysis: Sequencing of DNA from the husband and children of the proband, as well as 10 additional family members, revealed that only a daughter of the proband carried the R303W mutation. Clinical records showed that both the mother and daughter had been diagnosed with combined ADHD, according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders IV, and had been using stimulant therapy against this condition for several years before they were included in our study. A comparison of World Health Organization adult ADHD self-report scale 8 scores of 11 first and second degree family members revealed two additional individuals who scored above the threshold value for ADHD, but all scored lower than the two individuals carrying the R303W mutation, showing that it segregated with the categorical clinical diagnosis of ADHD, as well as the dimensional ADHD self-report scale scores. 8 In addition to ADHD, the mother had been treated with a selective serotonin reuptake inhibitor for an episode of major depression and scored positive for dysthymia using the MINI þ questionnaire, but no other psychiatric diagnoses were recorded for either patients. Both patients had normal developmental histories and rated their response to stimulant medication as 'excellent'. There was no evidence for consanguinity in this family.
The functional effect of the R303W mutation was studied in three different protein expression systems, that is, Escherichia coli, human embryonic kidney (HEK293) cells and rabbit reticulocyte lysates. 3 For comparison, wild-type (wt) TPH2 was produced. 3, 7 As shown in Figure 1 , the enzyme activity of TPH2 R303W was abolished in all expression systems (0.03-5% of wt TPH2). The HEK293 cell lysates contained identical amounts of mRNA for all constructs, as shown by real-time PCR (data not shown). Compared to wt TPH2, the R303W mutant had decreased solubility in all expression systems examined, compatible with a folding defect or increased hydrophobicity of the mutant protein.
The position of R303W was mapped on a threedimensional model of human TPH2, 7 showing that the mutation was located at the entry of the active site, in a structurally conserved region of the protein.
In the related enzyme phenylalanine hydroxylase, mutation of the corresponding amino acid (R270) is also associated with complete loss of enzyme activity and classical phenylketonuria. 9 Although the family structure does not allow us to formally prove strong segregation between ADHD and the R303W mutation, we propose that this complete loss-of-function mutation leads to a reduced serotonin synthesis, which in turn makes the mutation carriers susceptible to develop symptoms of ADHD and possibly other psychiatric disorders as well. The association of functional TPH2 variants with a clinical diagnosis of ADHD supports a role of serotonin in human disorders related to altered motor activity and cognitive processes, not necessarily limited to a specific diagnostic category. 10 It also illustrates that rare genetic variants with strong effects may be involved in the etiology of common psychiatric disorders, such as ADHD. The TPH2 enzyme activities of the  soluble and insoluble fractions were measured as described, 3,7 and the amount of TPH2 protein in the fractions was measured by western blotting. 7 (b) Relative amounts of TPH2maltose-binding protein fusion protein and TPH2 specific activity in soluble and insoluble fractions of Escherichia coli lysates were measured by comparing the band intensities of Coomassie-stained sodium dodecylsulfate polyacrylamide gels (30 mg of total protein in each sample) and enzyme activities were measured as described. 7 (c) Relative amounts of TPH2 protein and TPH2 specific activity in the soluble and insoluble fractions of in vitro transcribed and translated TPH2. The error bars indicate the s.d. of the measurements (n = 6). The differences in TPH activities between wt and mutant enzymes were significant in all expression systems (P < 0.003, t-test). n.d., not determined.
